NCT04523948

Brief Summary

The aim of this pilot intervention is to examine the acceptability of a harm reduction intervention approach to tobacco use for individuals with serious behavioral health disorders and its association with a decrease in smoking. The intervention uses a "dynamic" approach to patient choice, allowing participants the option to explore different strategies for harm reduction, while providing support from counselors in the process. Therefore, the investigators have chosen an observational study design in order to document and explore the acceptability and outcomes of the intervention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 30, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 23, 2020

Completed
1 month until next milestone

First Posted

Study publicly available on registry

August 24, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2022

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2023

Completed
Last Updated

September 28, 2021

Status Verified

September 1, 2021

Enrollment Period

2.8 years

First QC Date

July 23, 2020

Last Update Submit

September 22, 2021

Conditions

Keywords

Mental HeatlhSubstance UseHarm Reduction

Outcome Measures

Primary Outcomes (4)

  • Number of cigarettes smoked

    Self-reported number of cigarettes smoked per day

    Change in number of cigarettes smoked per day will be assessed using two time frames: 1) Baseline to 6 months post baseline; and 2) Post intervention which is change from baseline to 12 months post baseline.

  • Nicotine Dependence

    Fagerström Test for Nicotine Dependence, a self-reported scale rated from 0-10, with \>=5 indicating dependence (Heatherton et al., 1991).

    Change in nicotine dependence will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline

  • Carbon Monoxide

    Exhaled carbon monoxide level concentration reported in parts per million (ppm) using a breathalyzer assay

    Change in carbon monoxide level will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline

  • Salivary Tobacco Use

    Salivary tobacco use level reported in nicotine metabolites (cotinine)

    Change in salivary nicotine level will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline

Secondary Outcomes (3)

  • Smoking Decisional Balance

    Change in smoking decisional balance will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline

  • Challenges to Smoking Behavior Change

    Change in challenges to smoking behavior change will be assessed on two occasions: 1) during the intervention from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline.

  • Working Alliance Inventory

    Change in working alliance quality will be assessed using two time frames: 1) during the intervention, which is change from baseline to 6 months post baseline; and 2) after the intervention which is change from baseline to 12 months post baseline.

Study Arms (5)

Cohort One

Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.

Behavioral: Behavioral and pharmacological support to reduce combustible tobacco use.

Cohort Two

Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.

Behavioral: Behavioral and pharmacological support to reduce combustible tobacco use.

Cohort Three

Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.

Behavioral: Behavioral and pharmacological support to reduce combustible tobacco use.

Cohort Four

Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.

Behavioral: Behavioral and pharmacological support to reduce combustible tobacco use.

Cohort Five

Subjects will be invited to participate in brief weekly in person or telehealth behavioral support with the objective of reducing their rate of combustible tobacco use. Subjects will also be offered the choice of various conventional nicotine replacement aids, snus, electronic cigarette, varenicline or bupropion.

Behavioral: Behavioral and pharmacological support to reduce combustible tobacco use.

Interventions

Behavioral and pharmacological support to reduce combustible tobacco use.

Cohort FiveCohort FourCohort OneCohort ThreeCohort Two

Eligibility Criteria

Age21 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult individuals who are or have been served by public systems related to a mental health or substance use disorder and are currently using combustible tobacco.

You may qualify if:

  • Individuals who are formerly or currently being served by San Francisco Bay Area Public Health behavioral health providers. These will include individuals with psychotic, affective, anxiety, personality and substance use disorders.
  • Individuals who are not currently enrolled in another formal tobacco intervention or research study.
  • Are at least 21 years of age and able to speak English\*
  • Who score in the "low to moderate dependence" range on the Fagerstrom Test of Nicotine Dependence
  • Have used tobacco for at least two years
  • Express willingness to participate at least weekly in the intervention strategy
  • Express a desire to make some change in their tobacco use pattern
  • Express some reason to change their tobacco use pattern
  • Have the cognitive capacity to be able to sign a consent to participate in the research
  • A concerted effort will be made to recruit bilingual Chinese and Spanish language staff

You may not qualify if:

  • The individual does not currently smoke tobacco
  • Individuals younger than 21 years of age at the time of enrollment
  • Who score in the "low" range on the Fagerstrom Test of Nicotine Dependence
  • Have used tobacco for less than two years;
  • Express unwillingness to participate at least weekly in the intervention strategy
  • Decline an interest in making some change in their tobacco use pattern
  • Do not indicate the cognitive capacity to be able to sign a consent to participate in the research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

San Francisco Study Center

San Francisco, California, 94102, United States

RECRUITING

Related Publications (12)

  • Dickerson F, Stallings CR, Origoni AE, Vaughan C, Khushalani S, Schroeder J, Yolken RH. Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011. Psychiatr Serv. 2013 Jan;64(1):44-50. doi: 10.1176/appi.ps.201200143.

    PMID: 23280457BACKGROUND
  • Evins AE, Cather C, Laffer A. Treatment of tobacco use disorders in smokers with serious mental illness: toward clinical best practices. Harv Rev Psychiatry. 2015 Mar-Apr;23(2):90-8. doi: 10.1097/HRP.0000000000000063.

    PMID: 25747922BACKGROUND
  • Glasheen C, Hedden SL, Forman-Hoffman VL, Colpe LJ. Cigarette smoking behaviors among adults with serious mental illness in a nationally representative sample. Ann Epidemiol. 2014 Oct;24(10):776-80. doi: 10.1016/j.annepidem.2014.07.009. Epub 2014 Jul 30.

    PMID: 25169683BACKGROUND
  • Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev. 2018 May 31;5(5):CD000146. doi: 10.1002/14651858.CD000146.pub5.

    PMID: 29852054BACKGROUND
  • Jensen AB, Hounsgaard L. "I only smoke when I have nothing to do": a qualitative study on how smoking is part of everyday life in a Greenlandic village. Int J Circumpolar Health. 2013 Aug 5;72. doi: 10.3402/ijch.v72i0.21657. eCollection 2013.

    PMID: 23967409BACKGROUND
  • Lindson-Hawley N, Banting M, West R, Michie S, Shinkins B, Aveyard P. Gradual Versus Abrupt Smoking Cessation: A Randomized, Controlled Noninferiority Trial. Ann Intern Med. 2016 May 3;164(9):585-92. doi: 10.7326/M14-2805. Epub 2016 Mar 15.

    PMID: 26975007BACKGROUND
  • Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.

    PMID: 27734465BACKGROUND
  • Rae J, Pettey D, Aubry T, Stol J. Factors affecting smoking cessation efforts of people with severe mental illness: a qualitative study. J Dual Diagn. 2015;11(1):42-9. doi: 10.1080/15504263.2014.992096.

    PMID: 25491704BACKGROUND
  • Schroeder SA, Morris CD. Confronting a neglected epidemic: tobacco cessation for persons with mental illnesses and substance abuse problems. Annu Rev Public Health. 2010;31:297-314 1p following 314. doi: 10.1146/annurev.publhealth.012809.103701.

    PMID: 20001818BACKGROUND
  • Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016 Mar 24;3(3):CD008286. doi: 10.1002/14651858.CD008286.pub3.

    PMID: 27009521BACKGROUND
  • Twyman L, Bonevski B, Paul C, Bryant J. Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open. 2014 Dec 22;4(12):e006414. doi: 10.1136/bmjopen-2014-006414.

    PMID: 25534212BACKGROUND
  • Uppal N, Shahab L, Britton J, Ratschen E. The forgotten smoker: a qualitative study of attitudes towards smoking, quitting, and tobacco control policies among continuing smokers. BMC Public Health. 2013 May 3;13:432. doi: 10.1186/1471-2458-13-432.

    PMID: 23641875BACKGROUND

MeSH Terms

Conditions

Tobacco UseSubstance-Related DisordersHarm Reduction

Condition Hierarchy (Ancestors)

BehaviorChemically-Induced DisordersMental Disorders

Study Officials

  • Kevin McGirr, MS, MPH

    San Francisco Study Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kevin McGirr, MS, MPH

CONTACT

Joni Beemsterboer, MPH

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 23, 2020

First Posted

August 24, 2020

Study Start

January 30, 2020

Primary Completion

October 31, 2022

Study Completion

July 31, 2023

Last Updated

September 28, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

There is currently no plan to share IPD.

Locations